INSIGHTS ON CLINICAL TRIAL DESIGN
-
Increasing Participation In World-Class Cancer Research In Northwest Arkansas
Discover how data automation and integrated screening help community cancer centers offer clinical research as a standard care option, ensuring all patients have access to the latest treatments.
-
Choosing The Most Effective Method For Biopharmaceutical Development
Explore how the application of protein assays extend from basic research to the development of cutting-edge therapies, which makes them indispensable in the quest to improve human health.
-
Overcoming Barriers To Clinical Trial Participation In Oncology
Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.
-
When Early CRO Wins Quietly Create Long-Term Study Risk
Discover how overemphasizing early trial milestones can compromise long-term execution. Learn key strategies to build sustainable operational frameworks for lasting study success.
-
Patient Support Solutions For Clinical Trials5/14/2025
Learn how Greenphire leverages its more than 17 years of experience to deliver the most flexible and comprehensive patient-focused solutions and services.
-
We Can Fix What's Broken in Research—If We Solve the Right Problems4/11/2025
Addressing the root causes of inefficiencies in research is the only way to drive meaningful progress. Explore why tackling the right issues is essential to fixing broken research process.
-
Expedite Drug Development With An Integrated CDMO-CRO Model2/6/2026
From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
-
Retention Begins With Recruiting The Right-Fit Patients11/13/2025
Recruiting the right patients into a clinical trial is only half the battle. To combat attrition, sponsors must also institute measures that ensure patients remain comfortable and confident throughout the trial.
-
The Implications Of Semaglutide's Connect To Increased Risk Of NAION2/18/2025
Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
CLINICAL TRIAL DESIGN SOLUTIONS
-
If rater quality is a risk your study can't afford to take, now is the time to evaluate whether your current approach has the structure to support it.
-
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
-
Explore this suite of multichannel, patient-centered solutions that are powering rapid clinical trial education, engagement, and enrollment.
-
Get near real-time notifications when a potential trial candidate presents in the clinic, which will help enable recruitment before the window of opportunity closes.
-
Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.